Prospective longitudinal trends in body composition and clinical outcomes 3 years following sleeve gastrectomy

S Sherf-Dagan, S Zelber-Sagi, A Buch, N Bar, M Webb… - Obesity Surgery, 2019 - Springer
Obesity Surgery, 2019Springer
Abstract Background and Aims Longitudinal assessment of body composition following
bariatric surgery allows monitoring of health status. Our aim was to elucidate trends of
anthropometric and clinical outcomes 3 years following sleeve gastrectomy (SG). Methods A
prospective cohort study of 60 patients who underwent SG. Anthropometrics including body
composition analysis measured by multi-frequency bioelectrical impedance analysis, blood
tests, liver fat content measured by abdominal ultrasound and habitual physical activity were …
Background and Aims
Longitudinal assessment of body composition following bariatric surgery allows monitoring of health status. Our aim was to elucidate trends of anthropometric and clinical outcomes 3 years following sleeve gastrectomy (SG).
Methods
A prospective cohort study of 60 patients who underwent SG. Anthropometrics including body composition analysis measured by multi-frequency bioelectrical impedance analysis, blood tests, liver fat content measured by abdominal ultrasound and habitual physical activity were evaluated at baseline and at 6 (M6), 12 (M12), and 36 (M36) months post-surgery.
Results
Sixty patients (55% women, age 44.7 ± 8.7 years) who completed the entire follow-up were included. Fat mass (FM) was reduced significantly 1 year post-surgery (55.8 ± 11.3 to 26.7 ± 8.3 kg; P < 0.001) and then increased between 1 and 3 years post-operatively, but remained below baseline level (26.7 ± 8.3 to 33.1 ± 11.1 kg; P < 0.001). Fat free mass (FFM) decreased significantly during the first 6 months (64.7 ± 14.3 to 56.9 ± 11.8 kg; P < 0.001), slightly decreased between M6 and M12 and then reached a plateau through M36. Weight loss “failure” (< 50% excess weight loss) was noticed in 5.0% and 28.3% of patients at M12 and M36, respectively. Markers of lipid and glucose metabolism changed thereafter in parallel to the changes observed in FM, with the exception of HDL-C, which increased continuingly from M6 throughout the whole period analyzed (45.0 ± 10.2 to 59.5 ± 15.4 mg/dl; P < 0.001) and HbA1c which continued to decrease between M12 and M36 (5.5 ± 0.4 to 5.3 ± 0.4%; P < 0.001). There were marked within-person variations in trends of anthropometric and clinical parameters during the 3-year follow-up.
Conclusions
Weight regain primarily attributed to FM with no further decrease in FFM occurs between 1 and 3 years post-SG. FM increase at mid-term may underlie the recurrence of metabolic risk factors and can govern clinical interventions.
Springer
以上显示的是最相近的搜索结果。 查看全部搜索结果